Zepbound without insurance starts at $299 per month for the lowest dose if you buy directly through Eli Lilly’s self-pay program. That’s the cheapest legitimate route available right now, though your cost will rise as your dose increases. Several other options can bring the price down or help you access the medication, and the right path depends on whether you have no insurance at all or simply have a plan that won’t cover it.
Lilly’s Self-Pay Program Through LillyDirect
Eli Lilly sells Zepbound directly to patients through its online pharmacy platform, LillyDirect. This bypasses traditional pharmacy markup and offers the lowest prices available for the brand-name drug. You still need a valid prescription, but the ordering and delivery process happens online with home shipping.
The monthly prices through the Zepbound Self Pay Journey Program are:
- 2.5 mg: $299
- 5 mg: $399
- 7.5 mg: $449
- 10 mg: $449
- 12.5 mg: $449
- 15 mg: $449
These prices apply to single-dose vials, not the pen injectors. The vials contain the same medication but require you to draw the dose with a syringe rather than clicking a prefilled pen. For most people, this is a minor trade-off for significant savings.
There’s an important catch at higher doses. The $449 price for 7.5 mg through 15 mg only applies on your first fill and when you refill within 45 days of your previous delivery. If you miss that window, the price jumps considerably: $599 for 7.5 mg, $699 for 10 mg, $849 for 12.5 mg, and $1,049 for 15 mg. Setting a refill reminder is worth the effort.
The Savings Card for Covered but Denied Plans
If you do have commercial health insurance but your plan specifically excludes Zepbound, you’re in a different category from someone with no insurance at all. Lilly offers a savings card that brings the cost of the pen injector down to $499 per month for people in this situation. The card is valid through the end of 2026.
To qualify, you need a prescription for an FDA-approved use, commercial drug insurance that doesn’t cover Zepbound, and a signed HIPAA authorization. People on government insurance programs like Medicare, Medicaid, or Tricare are not eligible for this card. Neither are patients whose plans participate in alternate funding programs.
This card is less useful than the self-pay vial program for most people, since the vials through LillyDirect cost less at every dose level. But if you prefer the convenience of the prefilled pen and have a qualifying insurance plan, it’s an option.
Getting a Prescription Without a Primary Care Doctor
You need a prescription regardless of how you pay, and several telehealth platforms now offer weight management consultations specifically for medications like Zepbound. Services like Ro, Sesame, and WeightWatchers Clinic connect you with a prescriber online, typically for a monthly subscription fee on top of the medication cost. LillyDirect itself integrates with telehealth providers, so you can sometimes complete the prescription and ordering process in one place.
When comparing telehealth services, look at what the subscription actually includes. Some bundle ongoing check-ins and dose adjustments into a flat monthly fee. Others charge per visit. The prescription itself is the same either way, so the main variable is convenience and follow-up support.
Why Compounded Tirzepatide Is Risky Now
Compounded versions of tirzepatide (the active ingredient in Zepbound) were widely available at lower prices while the drug was on the FDA’s shortage list. That landscape has changed significantly. Tirzepatide no longer appears on the FDA’s drug shortage list, and it’s not on the approved bulk substances list for outsourcing facilities. This means large-scale compounding pharmacies can no longer legally produce it.
Smaller compounding pharmacies operating under individual prescriptions face restrictions too. The FDA considers a compounded version of tirzepatide to be “essentially a copy” of a commercially available drug if it contains the same ingredient at the same or similar strength and is given by the same route. Pharmacies filling more than four such prescriptions per month are at risk of enforcement action. The FDA has signaled it may still act against compounders producing substandard or unsafe products.
Compounded drugs never go through FDA review for safety, effectiveness, or manufacturing quality. With Lilly’s self-pay prices now starting at $299, the cost gap between compounded and brand-name Zepbound has narrowed enough that the trade-off in quality assurance is harder to justify.
Lilly Cares Does Not Cover Zepbound
Eli Lilly runs a patient assistance foundation called Lilly Cares that provides free medications to people who meet income requirements. Zepbound is not currently included in this program. The foundation covers a number of Lilly’s other medications, but weight management drugs are absent from every eligibility group. This could change in the future, but right now it’s not a viable path.
Using HSA, FSA, or Tax Deductions
If you have a health savings account or flexible spending arrangement from a current or former employer, you can use those pre-tax dollars to pay for Zepbound. The medication qualifies as a medical expense when prescribed to treat a diagnosed condition like obesity, hypertension, or heart disease.
Even without an HSA or FSA, your out-of-pocket Zepbound costs may be tax-deductible. The IRS allows you to deduct weight loss treatment expenses when a physician has diagnosed a specific disease that the treatment addresses. This means your Zepbound costs, potentially $3,588 to $5,388 per year at self-pay prices, can count toward your medical expense deduction. The limitation is that you can only deduct medical expenses that exceed 7.5% of your adjusted gross income, so this mainly helps people with significant total medical costs in a given year.
Clinical Trials as a Free Access Route
Eli Lilly and other research institutions periodically run clinical trials involving tirzepatide for various conditions. Participants in these trials typically receive the medication at no cost for the duration of the study. You can search for active trials at ClinicalTrials.gov by entering “tirzepatide” or “Zepbound” as a keyword and filtering by your location and enrollment status. Lilly also maintains a trial guide at trials.lillytrialguide.com. Keep in mind that trials have strict eligibility criteria, may involve placebo groups, and require regular visits and monitoring. This isn’t a reliable long-term access strategy, but it’s worth checking if you’re otherwise unable to afford treatment.
What a Realistic Budget Looks Like
Zepbound is a dose-escalation medication, meaning you start at the lowest dose and increase over time based on your response. Most people begin at 2.5 mg for four weeks, then move to 5 mg, with further increases possible up to 15 mg. Through LillyDirect’s self-pay program, your first month costs $299, your second month costs $399, and from the third month onward you’d pay $449 if you stay on schedule with refills.
That works out to roughly $5,100 for a full year if you reach and maintain one of the higher doses. Adding a telehealth subscription for ongoing prescriptions could add another $20 to $100 per month depending on the platform. Using an HSA or FSA effectively reduces your cost by your marginal tax rate, saving most people 22% to 32% on every dollar spent. At $449 per month, that brings the effective cost down to roughly $305 to $350 per month for someone in a typical tax bracket.